Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 393 Records) |
| Query Trace: Neoplasms and MDM2[original query] |
|---|
| IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation. Acta neuropathologica communications 2021 12 9 (1): 200. Barresi Valeria, Simbolo Michele, Mafficini Andrea, Martini Maurizio, Calicchia Martina, Piredda Maria Liliana, Ciaparrone Chiara, Bonizzato Giada, Ammendola Serena, Caffo Maria, Pinna Giampietro, Sala Francesco, Lawlor Rita Teresa, Ghimenton Claudio, Scarpa Al |
| Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review. Frontiers in oncology 2022 12 973077. Yu Meijia, Zhang Qin, Zhao X |
| Alterations in p53 Influence hTERT, VEGF and MMPs Expression in Oral Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 2022 9 23 (9): 3141-3149. Singh Ragini D, Patel Kinjal A, Patel Jayendra B, Patel Prabhudas |
| Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations. Cancers 2022 08 14 (16): . Zhao Rongjie, Li Hongshen, Ge Weiting, Zhu Xiuming, Zhu Liang, Wan Xiangbo, Wang Guanglan, Pan Hongming, Lu Jie, Han Weido |
| A common pathway to cancer: Oncogenic mutations abolish p53 oscillations. Progress in biophysics and molecular biology 2022 6 174 28-40. Xiong Lingyun, Garfinkel Al |
| Genome-wide CRISPR/Cas9 screening for therapeutic targets in NSCLC carrying wild-type TP53 and receptor tyrosine kinase genes. Clinical and translational medicine 2022 6 12 (6): e882. Wang Qianqian, Li Jun, Zhu Jing, Mao Jiaqi, Duan Chao, Liang Xiao, Zhu Lingyun, Zhu Mengyan, Zhang Zhihong, Lin Fan, Guo Renh |
| Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients. Cancer medicine 2022 May . Gan Meifu, Zhang Chen, Qiu Liqing, Wang Yue, Bao Hua, Yu Ruoying, Liu Rui, Wu Xue, Shao Yang, Hou Peifeng, Fei Zhengl |
| The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 4 28 (12): 2669-2678. Sihag Smita, Nussenzweig Samuel C, Walch Henry S, Hsu Meier, Tan Kay See, De La Torre Sergio, Janjigian Yelena Y, Maron Steven B, Ku Geoffrey Y, Tang Laura H, Shah Pari M, Wu Abraham, Jones David R, Solit David B, Schultz Nikolaus, Ganesh Karuna, Berger Michael F, Molena Danie |
| Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer. Journal of oncology 2022 4 2022 1763778. Li Yue, Li Chong, Jiang Ya, Han Xue, Liu Sisi, Xu Xiuxiu, Tang Wanxiangfu, Ou Qiuxiang, Bao Hua, Wu Xue, Shao Yang, Xing Minyan, Zhang Yixiang, Wang Yuezh |
| GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers. Communications biology 2022 4 5 (1): 373. Bianco Gaia, Coto-Llerena Mairene, Gallon John, Kancherla Venkatesh, Taha-Mehlitz Stephanie, Marinucci Mattia, Konantz Martina, Srivatsa Sumana, Montazeri Hesam, Panebianco Federica, Tirunagaru Vijaya G, De Menna Marta, Paradiso Viola, Ercan Caner, Dahmani Ahmed, Montaudon Elodie, Beerenwinkel Niko, Kruithof-de Julio Marianna, Terracciano Luigi M, Lengerke Claudia, Jeselsohn Rinath M, Doebele Robert C, Bidard François-Clément, Marangoni Elisabetta, Ng Charlotte K Y, Piscuoglio Salvato |
| Association between ??53, MDM2 and NQO1 gene polymorphisms and viral load among women with human papillomavirus. Vavilovskii zhurnal genetiki i selektsii 2022 3 26 (1): 59-64. AlBosale A H, Mashkina E |
| Systematic review and meta-analysis of genomic alterations in acral melanoma. Pigment cell & melanoma research 2022 3 35 (3): 369-386. Broit Natasa, Johansson Peter A, Rodgers Chloe B, Walpole Sebastian T, Hayward Nicholas K, Pritchard Antonia |
| p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations. Diagnostic pathology 2022 12 17 (1): 92. Sung You-Na, Kim Deokhoon, Kim Jih |
| ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications. Journal of the National Cancer Institute 2022 1 114 (5): 761-770. El Jabbour Tony, Misyura Maksym, Cowzer Darren, Zimmermann Michal, Rimkunas Victoria, Marra Antonio, Derakhshan Fatemeh, Selenica Pier, Parilla Megan, Setton Jeremy S, Ceyhan-Birsoy Ozge, Kemel Yelena, Catchings Amanda, Ranganathan Megha, Ku Geoffrey Y, Janjigian Yelena Y, Zinda Michael, Koehler Maria, Stadler Zsofia, Shia Jinru, Reis-Filho Jorge S, Mandelker Dia |
| Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma. Journal of gastrointestinal oncology 2021 Dec 12 (6): 2631-2642. Zheng Yuanwen, Qin Yejun, Gong Wei, Li Hongguang, Li Bin, Wang Yu, Chao Baoting, Zhao Shulei, Liu Luguang, Yao Shuzhan, Shi Junping, Shi Xiaoliang, Wang Kai, Xu Shife |
| Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials. Annals of oncology : official journal of the European Society for Medical Oncology 2023 9 . F André, F Su, N Solovieff, G Hortobagyi, S Chia, P Neven, A Bardia, D Tripathy, Y-S Lu, A Lteif, T Taran, N Babbar, D Slamon, C L Artea |
| Higher 13-Gene-Estimated TMB Detected from Plasma ctDNA is Associated with Worse Outcome for T-Cell Lymphoma Patients. Advanced biology 2023 9 e2300042. Cunte Chen, Ling Huang, Zheng Chen, Qiuxiang Ou, Sichu Liu, Xinmiao Jiang, Feili Chen, Xiaojuan Wei, Hanguo Guo, Yang Shao, Chengwu Zeng, Yangqiu Li, Wenyu |
| Clinical and Genomic Characteristics of Patients with HR+, HER2- Metastatic Breast Cancer Following Progression on a CDK4 and 6 Inhibitor. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 6 . Xi Rao, Yongmei Chen, Julie Beyrer, Emily Nash Smyth, Claudia Morato Guimaraes, Lacey M Litchfield, Lee Bowman, Garreth W Lawrence, Amit Aggarwal, Fabrice And |
| Identification of MDM2 as a prognostic and immunotherapeutic biomarker in a comprehensive pan-cancer analysis: A promising target for breast cancer, bladder cancer and ovarian cancer immunotherapy. Life sciences 2023 6 121832. Jialiang Zheng, Fenglin Miao, Zhao Wang, Yuan Ma, Zhenhang Lin, Yaqin Chen, Xu Kong, Yue Wang, Aobo Zhuang, Ting Wu, Wengang |
| Sex-Specific Associations of MDM2 and MDM4 Variants with Risk of Multiple Primary Melanomas and Melanoma Survival in Non-Hispanic Whites. Cancers 2023 6 15 (10): . Sarah V Ward, Isidora Autuori, Li Luo, Emily LaPilla, Sarah Yoo, Ajay Sharma, Klaus J Busam, David W Olilla, Terence Dwyer, Hoda Anton-Culver, Roberto Zanetti, Lidia Sacchetto, Anne E Cust, Richard P Gallagher, Peter A Kanetsky, Stefano Rosso, Colin B Begg, Marianne Berwick, Nancy E Thomas, Irene Orlow, |
| Association of Interactions between Metabolic 'Caretaker' Genes, p53, MDM2, and Tobacco Use with the Risk of Oral Cancer: A Multifactor Dimensionality Reduction Approach. Asian Pacific journal of cancer prevention : APJCP 2023 4 24 (4): 1231-1237. Ragini D Singh, Kinjal A Patel, Jayendra B Patel, Prabhudas S Pat |
| Gene variations related to the hepatocellular carcinoma: results from a field synopsis and Bayesian revaluation. Gene 2023 3 147392. Penha Mesquita Abel, Victor Oliveira Monteiro André, Luiz Araújo Bentes Leal Alessandro, Dos Santos Pessoa Larissa, de Siqueira Amorim Júnior José, Rogério Souza Monteiro José, Andrade de Sousa Aline, Fernando Pereira Vasconcelos Daniel, Carolina Alves de Oliveira Ana, Leão Pereira Adenilson, Rodolfo Pereira da Silva Feli |
| MDM2 amplification is rare in gastric cancer. Virchows Archiv : an international journal of pathology 2023 10 . Samir Abdullazade, Hans-Michael Behrens, Sandra Krüger, Jochen Haag, Christoph Röck |
| Genomic landscape of cutaneous, acral, mucosal, and uveal melanoma in Japan: analysis of clinical comprehensive genomic profiling data. International journal of clinical oncology 2024 9 . Tokimasa Hida, Junji Kato, Masashi Idogawa, Takashi Tokino, Hisashi Uha |
| Genetic polymorphisms in FABP2, CYP2E1, and TP53 genes are potentially associated with colorectal cancer susceptibility. Scientific reports 2024 9 14 (1): 20464. Maryam Ijaz, Chien-Chin Chen, Rana Khalid Iqbal, Hafiza Aneela Farooq, Rubaida Mehmood, Muhammad Asif, Atif Akbar, Adil Khan, Waseem Ijaz, Mourad Ben Said, Gezahign Fentahun Wondmie, Samir Ibenmoussa, Mohammad K Okla, Furhan Iqb |
| Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology. Lung cancer (Amsterdam, Netherlands) 2024 9 196 107935. Jennifer A Marks, Nishant Gandhi, Balazs Halmos, Melina E Marmarelis, So Yeon Kim, Lyudmila Bazhenova, Suresh S Ramalingam, Joanne Xiu, Phillip Walker, Matthew J Oberley, Patrick C Ma, Stephen V L |
| Genomic Profiling of Small Intestine Cancers From a Real-World Data Set Identifies Subgroups With Actionable Alterations. JCO precision oncology 2024 8 8 e2300425. Hiroyuki Takeda, Hiroyuki Yamamoto, Ritsuko Oikawa, Kumiko Umemoto, Hiroyuki Arai, Takuro Mizukami, Kazuki Ogawa, Yoshiyasu Uchida, Yusuke Nagata, Yohei Kubota, Ayako Doi, Yoshiki Horie, Takashi Ogura, Naoki Izawa, Jay A Moore, Ethan S Sokol, Yu Sunaka |
| Whole-exome sequencing reveals novel cancer genes and actionable targets in biliary tract cancers in primary sclerosing cholangitis. Hepatology communications 2024 7 8 (7): . Marit M Grimsrud, Michael Forster, Benjamin Goeppert, Georg Hemmrich-Stanisak, Irmi Sax, Krzysztof Grzyb, Peder R Braadland, Alphonse Charbel, Carmen Metzger, Thomas Albrecht, Tim Alexander Steiert, Matthias Schlesner, Michael P Manns, Arndt Vogel, Sheraz Yaqub, Tom H Karlsen, Peter Schirmacher, Kirsten M Boberg, Andre Franke, Stephanie Roessler, Trine Folsera |
| Genomic profiling and comparative analysis of male versus female metastatic breast cancer across subtypes. Breast cancer research : BCR 2024 7 26 (1): 118. Arun Kadamkulam Syriac, Nitish Singh Nandu, Allison Clark, Mehrad Tavallai, Dexter X Jin, Ethan Sokol, Kimberly McGregor, Jeffrey S Ross, Natalie Danziger, Jose Pablo Leo |
| Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort. Oral oncology 2024 4 152 106807. Norihisa Ichimura, Yusuke Urata, Takeru Kobayashi, Hideharu Hi |
- Page last reviewed:Feb 1, 2024
- Content source: